Neglected Tropical Disease Treatment Market
完整報告名稱與涵蓋範圍
Neglected Tropical Disease Treatment Market Size, Share & Trends Analysis Report By Drug Class (Anti-Parasite, Antifungal, Antibiotics, Others), By Disease Type (Leishmaniasis, Schistosomiasis, Lymphatic Filariasis, Chagas Disease, African Trypanosomiasis, Others), By Distribution Channel (Direct Sales, Indirect Sales), By Region, And By Segment Forecasts, 2024-2031
報告摘要
Valued at USD 2.9 billion as of 2023, the global Neglected Tropical Disease Treatment Market is forecasted to climb to USD 4.4 billion by 2031, reflecting a compound annual growth rate of 5.3% over the 2024–2031 period.
The Neglected Tropical Disease Treatment sector involves intended to address infectious diseases that l. This domain has witnessed pronounced transformation owing to technological breakthroughs and shifting healthcare dynamics.
Market momentum is propelled by growing need advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
Regional dynamics show North America and Europe as established hubs, with the Asia-Pacific region forecasted to deliver the strongest growth trajectory through the forecast period, propelled by demographic shifts and policy support.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Neglected Tropical Disease Treatment Market Snapshot
Chapter 4. Global Neglected Tropical Disease Treatment Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2031
4.8. Global Neglected Tropical Disease Treatment Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Neglected Tropical Disease Treatment Industry Trends
Chapter 5. Neglected Tropical Disease Treatment Market Segmentation 1: By Drug Class, Estimates & Trend Analysis
5.1. Market Share by Drug Class, 2023 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Drug Class:
5.2.1. Anti-Parasite
5.2.2. Antifungal
5.2.3. Antibiotics
5.2.4. Others
Chapter 6. Neglected Tropical Disease Treatment Market Segmentation 2: By Disease Type, Estimates & Trend Analysis
6.1. Market Share by Disease Type, 2023 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Disease Types:
6.2.1. Leishmaniasis
6.2.2. Schistosomiasis
6.2.3. Lymphatic Filariasis
6.2.4. Chagas Disease
6.2.5. African Trypanosomiasis
6.2.6. Others
Chapter 7. Neglected Tropical Disease Treatment Market Segmentation 3: By Distribution Channel, Estimates & Trend Analysis
7.1. Market Share by Distribution Channel, 2023 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following Distribution Channels:
7.2.1. Direct Sales
7.2.2. Indirect Sales
Chapter 8. Neglected Tropical Disease Treatment Market Segmentation 6: Regional Estimates & Trend Analysis
8.1. Global Neglected Tropical Disease Treatment Market, Regional Snapshot 2023 & 2031
8.2. North America
8.2.1. North America Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.2.1.1. US
8.2.1.2. Canada
8.2.2. North America Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Drug Class, 2024-2031
8.2.3. North America Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
8.2.4. North America Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.3. Europe
8.3.1. Europe Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.3.1.1. Germany
8.3.1.2. U.K.
8.3.1.3. France
8.3.1.4. Italy
8.3.1.5. Spain
8.3.1.6. Rest of Europe
8.3.2. Europe Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Drug Class, 2024-2031
8.3.3. Europe Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
8.3.4. Europe Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.4. Asia Pacific
8.4.1. Asia Pacific Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.4.1.1. India
8.4.1.2. China
8.4.1.3. Japan
8.4.1.4. Australia
8.4.1.5. South Korea
8.4.1.6. Hong Kong
8.4.1.7. Southeast Asia
8.4.1.8. Rest of Asia Pacific
8.4.2. Asia Pacific Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Drug Class, 2024-2031
8.4.3. Asia Pacific Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
8.4.4. Asia Pacific Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts By Distribution Channel, 2024-2031
8.5. Latin America
8.5.1. Latin America Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2031
8.5.1.1. Brazil
8.5.1.2. Mexico
8.5.1.3. Rest of Latin America
8.5.2. Latin America Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Drug Class, 2024-2031
8.5.3. Latin America Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
8.5.4. Latin America Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
8.6. Middle East & Africa
8.6.1. Middle East & Africa Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.6.1.1. GCC Countries
8.6.1.2. Israel
8.6.1.3. South Africa
8.6.1.4. Rest of Middle East and Africa
8.6.2. Middle East & Africa Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Drug Class, 2024-2031
8.6.3. Middle East & Africa Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Disease Type, 2024-2031
8.6.4. Middle East & Africa Neglected Tropical Disease Treatment Market Revenue (US$ Million) Estimates and Forecasts by Distribution Channel, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Thermo Fisher Scientific, Inc.
9.2.1.1. Business Overview
9.2.1.2. Key Product/Service Offerings
9.2.1.3. Financial Performance
9.2.1.4. Geographical Presence
9.2.1.5. Recent Developments with Business Strategy
9.2.2. F. Hoffmann-La Roche Ltd.
9.2.3. Omega Diagnostics Group PLC
9.2.4. Abbott
9.2.5. Oscar Medicare Pvt. Ltd.
9.2.6. Merck Ltd.
9.2.7. Genome Diagnostics Pvt. Ltd.
9.2.8. ZeptoMetrix
9.2.9. Bayer AG,
9.2.10. GlaxoSmithKline plc
9.2.11. Novartis AG
9.2.12. Pfizer, Inc.
9.2.13. Eisai Co. Ltd.
9.2.14. Sanofi
9.2.15. Astellas Pharma
9.2.16. Takeda Pharmaceutical Company Limited
9.2.17. Gilead Sciences
9.2.18. Other Market Players
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們